Oppenheimer Starts Ligand Pharma (LGND) at Outperform
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $290.60 +0.64%
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Rating Summary:
14 Buy, 5 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 18 | New: 6
Join SI Premium – FREE
Oppenheimer initiates coverage on Ligand Pharma (NASDAQ: LGND) with a Outperform rating and a price target of $135.00.
For an analyst ratings summary and ratings history on Ligand Pharma click here. For more ratings news on Ligand Pharma click here.
Shares of Ligand Pharma closed at $101.35 yesterday.
You May Also Be Interested In
- UBS Starts Nuvama Wealth Management (NUVAMA:IN) at Buy
- Piper Sandler Starts Jasper Therapeutics (JSPR) at Overweight
- Deutsche Bank Starts Hochtief AG (HOT:GR) (HOCFF) at Hold
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
